Pasithea Therapeutics (KTTA) Shares Issued (2021 - 2025)

Pasithea Therapeutics recorded quarterly Shares Issued of $51.2 million in Q4 2025, up 1899.01% quarter-over-quarter from $2.6 million in Q2 2025, and up 10735.5% year-over-year from N/an in Q4 2024.

Pasithea Therapeutics' Shares Issued history runs 2 years deep, the most recent figure standing at $51.2 million for Q4 2025.

  • In Q4 2025, Shares Issued rose 10735.5% year-over-year to $51.2 million; the TTM figure through Dec 2025 stood at $55.4 million (changed N/A YoY), while the FY2025 annual figure was $55.4 million, up 1126.94% from the prior year.
  • Shares Issued came in at $51.2 million for Q4 2025 at Pasithea Therapeutics, up from $2.6 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $51.2 million in Q4 2025 to a low of -$481499.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 5.40 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 27.00 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 163.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 13.16 Mn
10 Pasithea Therapeutics 17.41 Mn 17.41 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 53.41 Mn
Dec 31, 2025 53.41 Mn
Sep 30, 2025 730,782.00
Sep 30, 2025 730,782.00
Jun 30, 2025 1.28 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 871.00
Mar 31, 2025 871.00
Dec 31, 2024 -481,499.00
Dec 31, 2024 -481,499.00
Sep 30, 2024 4.50 Mn
Sep 30, 2024 4.50 Mn
Dec 31, 2021 5.79 Mn
Dec 31, 2021 5.79 Mn